News

2016 Jun 29

FDA grants Napabucasin orphan status for gastric cancer

The FDA has granted an orphan drug designation to the STAT3-targeted agent napabucasin as a treatment for patients with gastric or gastroesophageal junction cancer, based on early-phase research by Manish Shah, M.D. Read more

2016 Jun 28

Leonard named as 2016 Manhattan Light The Night Corporate Chair

The New York City Chapter of The Leukemia & Lymphoma Society (LLS) has announced John P. Leonard, M.D., as its 2016 Manhattan Light The Night® corporate chair. Read more

2016 Jun 28

Weill Cornell team publishes details of precision medicine knowledgebase of somatic tumor mutations

Olivier Elemento, Ph.D., and colleagues describe their data model that links variants to both tumor- and tissue-specific interpretations. Read more

2016 Jun 28

Device registry required to determine efficacy of newest prostate cancer treatment

Jim Hu, M.D., weighs in on new prostate cancer treatment, high-intensity focused ultrasound. Read more

2016 Jun 27

Mantle cell lymphoma treatment: plus ça change…

Peter Martin, M.D., comments on the results of a new immunochemotherapy regimen for the treatment of mantle cell lymphoma. Read more

2016 Jun 24

Ablation of small renal cancer associated with “significantly lower costs” than either partial or radical nephrectomy

For older patients with small (T1a) renal cancer, percutaneous ablation is associated with much lower costs than partial or radical nephrectomy, according to Adam D. Talenfeld, M.D. Read more

Marcin Imielinski, M.D., Ph.D., computational biologist at Meyer Cancer Center, Weill Cornell Medicine

2016 Jun 22

How precision medicine will shift from research to clinical care

Marcin Imielinski, M.D., Ph.D., discusses the potential of precision medicine or cancer care. Read more

Tessa Cigler, M.D. uses cold caps to preserve hair during chemotherapy

2016 Jun 21

Preventing hair loss from chemotherapy

It was a patient who inspired Tessa Cigler, M.D., to investigate the use of "cold caps" to prevent hair loss during chemotherapy. Read more

2016 Jun 20

Epigenome evolution may play key role in cancer progression

Certain types of cancer may be even more shifty and difficult to target than previously thought, due to continuous changes in cell programming. Read more

2016 Jun 16

Relaxation techniques ease patients' fear, anxiety about radiation treatments

A pilot project in radiation oncology has found that a relaxation wellness intervention can provide relief for anxious patients. Read more

Cancer immunologist Sandra Demaria, M.D., of the Meyer Cancer Center, is using radiation to transform tumors into personalized vaccines

2016 Jun 15

More evidence needed in using radiotherapy with immunotherapy

Despite very promising pre-clinical results and some clinical success, there is still much need to generate solid evidence demonstrating the efficacy of combining radiation with immunotherapy, according to Silvia Formenti, M.D., and Sandra Demaria, M.D. Read more

2016 Jun 12

Cancer drug prices higher in U.S., yet relatively affordable

David Nanus, M.D., discusses a study that examined the relative cost of cancer drugs. Read more

2016 Jun 09

The Pediatric Oncologist Paying It Forward at the Mini 10K

Lisa Roth, M.D., on running a race on behalf of a patient and herself, as a lymphoma survivor. Read more

2016 Jun 07

Chimeric antigen receptor T cells exhibit efficacy in advanced lymphoma

John Leonard, M.D., comments on research into the use of engineered CAR-T cells in the treatment of aggressive lymphomas. Read more

2016 Jun 06

FDA approves drug combo for kidney cancer

Ana Molina, M.D., comments on a new treatment for kidney cancer. Read more

2016 Jun 06

Sharing our collective wisdom at ASCO16

A variety of Meyer Cancer Center research and clinical results were showcased at the ASCO Annual Meeting in Chicago Read more

2016 Jun 06

Innovative immunotherapy more effective in treating an aggressive lymphoma than chemotherapy

A drug that recruits immune cells to fight an aggressive form of lymphoma that disproportionately affects minorities in the United States appears to be more effective than chemotherapy, according to Adrienne Phillips, M.D. Read more

2016 Jun 06

Biomarker confirms efficacy of early drug switch for prostate cancer patients

Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response, according to Scott Tagawa, M.D. and Paraskevi Giannakakou, Ph.D. Read more

2016 Jun 05

Young neurosurgeon embraces new technologies to save lives

Profile of Rohan Ramakrishna, M.D., and some of the novel methods he is using to tackle brain tumors. Read more

2016 Jun 05

CASTOR combination is promising treatment for multiple myeloma

Ruben Niesvizky, M.D., comments on a study that tested a new drug combination (daratumumab+bortezomib+dexamethasone) to treat multiple myeloma Read more

News

FDA grants Napabucasin orphan status for gastric cancer

Leonard named as 2016 Manhattan Light The Night Corporate Chair

Weill Cornell team publishes details of precision medicine knowledgebase of somatic tumor mutations

Device registry required to determine efficacy of newest prostate cancer treatment

Mantle cell lymphoma treatment: plus ça change…

Ablation of small renal cancer associated with “significantly lower costs” than either partial or radical nephrectomy

How precision medicine will shift from research to clinical care

Preventing hair loss from chemotherapy

Epigenome evolution may play key role in cancer progression

Relaxation techniques ease patients' fear, anxiety about radiation treatments

More evidence needed in using radiotherapy with immunotherapy

Cancer drug prices higher in U.S., yet relatively affordable

The Pediatric Oncologist Paying It Forward at the Mini 10K

Chimeric antigen receptor T cells exhibit efficacy in advanced lymphoma

FDA approves drug combo for kidney cancer

Sharing our collective wisdom at ASCO16

Innovative immunotherapy more effective in treating an aggressive lymphoma than chemotherapy

Biomarker confirms efficacy of early drug switch for prostate cancer patients

Young neurosurgeon embraces new technologies to save lives

CASTOR combination is promising treatment for multiple myeloma

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters